McLean Industries, Inc. v. Medical Laboratory Automation, Inc. (In Re McLean Industries, Inc.)

96 B.R. 440, 20 Collier Bankr. Cas. 2d 829, 1989 Bankr. LEXIS 178, 19 Bankr. Ct. Dec. (CRR) 46, 1989 WL 12166
CourtUnited States Bankruptcy Court, S.D. New York
DecidedFebruary 14, 1989
Docket19-22391
StatusPublished
Cited by15 cases

This text of 96 B.R. 440 (McLean Industries, Inc. v. Medical Laboratory Automation, Inc. (In Re McLean Industries, Inc.)) is published on Counsel Stack Legal Research, covering United States Bankruptcy Court, S.D. New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
McLean Industries, Inc. v. Medical Laboratory Automation, Inc. (In Re McLean Industries, Inc.), 96 B.R. 440, 20 Collier Bankr. Cas. 2d 829, 1989 Bankr. LEXIS 178, 19 Bankr. Ct. Dec. (CRR) 46, 1989 WL 12166 (N.Y. 1989).

Opinion

DECISION

HOWARD C. BUSCHMAN, III, Bankruptcy Judge.

This adversary proceeding, commenced by the Debtor, McLean Industries, Inc. (“McLean” or “Debtor”), seeks a judgment of specific performance compelling Medical Laboratory Automation, Inc. (“MLA”) to issue shares of stock pursuant to an option held by McLean. Three principal issues of bankruptcy administration are raised: whether an entity that is neither a creditor nor a shareholder may refuse to perform a pre-petition option timely exercised by the Debtor on the grounds that (i) the Debtor failed to give notice to creditors as required by 11 U.S.C. § 363(b)(1), (ii) the expenditure of funds to exercise might not qualify under 11 U.S.C. § 345 and (iii) the Debtor has yet to assume the Agreement in which the Option is contained. Jurisdiction over this adversary proceeding is vested in this Court pursuant to 28 U.S.C. § 1334 and § 157(b)(1). 1 Trial on stipulated facts was held on January 4, 1989.

I

McLean is a holding company. Its principal direct and indirect subsidiaries are two former exceptionally large shipping companies known as United States Lines, Inc. and United States Lines (S.A.), Inc. These three companies and another subsidiary filed bankruptcy petitions with this Court on November 24, 1986 under Chapter 11 of the Bankruptcy Code, 11 U.S.C. § 1101 et seq. (1986) (the “Bankruptcy Code” or the “Code”) and have continued as debtors-in-possession pursuant to §§ 1107 and 1108 of the Code. McLean has other subsidiary companies and owns stock in other publicly traded companies. Exhibits A, D. 2 For *442 general descriptions of these estates, see In re McLean Industries, Inc. 70 B.R. 852 (Bankr.S.D.N.Y.1987); In re McLean Industries, Inc., 87 B.R. 830 (Bankr.S.D.N.Y.1987).

MLA is a closely held corporation organized under the laws of New York with its principal place of business in Pleasantville, New York. Stipulation If 4. Its stock is privately held and is not traded on any public exchange or market. Stipulation 11114, 32. MLA is not a creditor or equity holder in any of these Chapter 11 cases and has not filed a proof of claim or interest. Stipulation ¶¶ 9, 38.

McLean entered into a sales contract (the “Agreement”) on April 13, 1977 with MLA under which McLean sold and MLA purchased Mobilizer Medical Products (“MMP”), a wholly owned subsidiary of McLean. Stipulation ¶ 16. In the Agreement, McLean received, inter alia, an option to purchase up to llh% of MLA’s outstanding stock or 64,344 shares at a price of $5.28 per share (the “Option”). Exhibit I, 11115(a), (b). Upon any partial or full exercise of the Option by McLean, MLA agreed to issue the number of shares being purchased in the following proportions: two thirds (%) Class A Common Stock (voting), $.01 par value and one-third (Vs) convertible Class B (non-voting), $.01 par value (the “Option Stock”). Ibid. The Option was exercisable for a period of 10 years from the date of the Agreement. Id., ¶ 5.

Malcolm P. McLean is the founder of McLean, owner of the bulk of its outstanding stock and long time Chairman of its Board of Directors. In October 1986, McLean’s controller, Kevin J. Baxley, consulted a stock analysis service report regarding the medical supply industry, examined MLA’s financial statements and estimated the MLA shares subject to the Option to be worth $1,708,453.00 after subtracting the Option exercise price. Exhibit J. In an October 1986 interoffice memorandum, Mr. McLean instructed Baxley, “Kevin, let’s stay on top of our right to buy this stock and not let this date slip by,” Exhibit K, and then or some time later ordered the Option be exercised. Hiltzheimer Deposition 52. In the Spring of 1987, the then Secretary and Assistant Treasurer of McLean, John D. McCown, estimated the value of the MLA stock subject to the Option to be worth over $2 million. McCown Deposition 114.

On or about April 8, 1987, Allen L. Stevens, Vice President and Treasurer of McLean, sent written notice to MLA informing it of McLean’s exercise of the Option to purchase 64,344 shares of MLA stock and tendered a certified check in the amount of $339,736.32. Exhibit M. That same letter rejected an offer by MLA to purchase the Option for $25,000. On April 24, 1987, counsel for MLA responded to McLean’s tender in a letter stating that the exercise of the Option was ineffective since it was outside of the ordinary course of business and therefore required prior bankruptcy court approval. Exhibit N. The letter indicated that McLean’s certified check was to be returned to McLean.

A special meeting of McLean’s Board of Directors was held on April 28, 1987. Exhibit P. While not on the agenda for the meeting, McLean’s exercise of the Option and MLA’s refusal to issue the stock were discussed. Although Stevens had informed the Chief Executive Officer of McLean, Charles Hiltzheimer, of the existence of the Option in an informal conversation in March of 1987, Hiltzheimer Deposition 43-44, and thought Hiltzheimer had approved its exercise, McCown Deposition 133-34, Hiltzheimer advised the Board that Mr. Stevens' letter of April 8, 1987 was sent and the check for $339,736.32 was issued without his knowledge. Exhibit P at 2. Hiltzheimer accordingly became angry and embarassed because a matter of which he was unaware or had forgotten, Hiltzheimer Deposition 44, came up before the Board and he had not so informed the creditors committee. Hiltzheimer Deposition 48-55. The minutes of the meeting indicate that Hiltzheimer was given assurance that no further actions of this type would be taken without his approval. Exhibit P at 2.

*443 Hiltzheimer’s anger was not aroused by the business judgment behind the exercise of the Option, but rather, at the lack of courtesy demonstrated towards him in failing, in his view, to notify him of the exercise of the Option. Hiltzheimer Deposition 52. He was more concerned with the form than with the substance and Mr. McLean apologized for the lack of courtesy. Id. at 55.

Hiltzheimer’s uneasiness was undoubtedly attributable to his having come to McLean and United States Lines as chief executive officer in November of 1986 on the eve of the filing of the Chapter 11 petitions. McCown Deposition 67. The United States Lines and United States Lines (S.A.) cases were in a crisis mode requiring urgency, Hiltzheimer Deposition 42, and the environment was chaotic. Id. at 24. Hilt-zheimer's “primary emphasis ... was to determine if [he] could salvage something of value out of the U.S. Lines operation and that’s where the focus, [his] focus was. About 99 percent.” Id. at 42 lines 23-25, 43 lines 1-3.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

In Re Dana Corp.
350 B.R. 144 (S.D. New York, 2006)
In Re Travelot Co.
286 B.R. 462 (S.D. Georgia, 2002)
In Re Patient Education Media, Inc.
221 B.R. 97 (S.D. New York, 1998)
In Re Keim
212 B.R. 493 (D. Maryland, 1997)
In Re Martin Paint Stores
199 B.R. 258 (S.D. New York, 1996)
In Re Caldor, Inc.-NY
193 B.R. 182 (S.D. New York, 1996)
In Re Columbia Gas Systems Inc.
33 F.3d 294 (Third Circuit, 1994)
In Re Consumer Health Services of America, Inc.
171 B.R. 917 (District of Columbia, 1994)
In Re Cavalieri
142 B.R. 710 (E.D. Pennsylvania, 1992)
In Re Chateaugay Corp.
136 B.R. 79 (S.D. New York, 1992)
In Re FRG, Inc.
107 B.R. 461 (S.D. New York, 1989)
In Re Sandhurst Securities, Inc.
96 B.R. 451 (S.D. New York, 1989)

Cite This Page — Counsel Stack

Bluebook (online)
96 B.R. 440, 20 Collier Bankr. Cas. 2d 829, 1989 Bankr. LEXIS 178, 19 Bankr. Ct. Dec. (CRR) 46, 1989 WL 12166, Counsel Stack Legal Research, https://law.counselstack.com/opinion/mclean-industries-inc-v-medical-laboratory-automation-inc-in-re-nysb-1989.